risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders

Clicks: 165
ID: 245150
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #53 of 57 articles by views in advances in skin & wound care

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Totally implantable vascular access devices (TIVADs) are commonly used in conjunction with enzyme replacement therapy (ERT) for lysosomal storage disorders (LSDs). This case series describes potential complications associated with long-term TIVAD use, such as compromise of skin integrity, infection, or port failures. Best practices and skilled specialists are essential for minimizing complications from long-term TIVAD use for ERT. Keywords: Mucopolysaccharidosis, Enzyme replacement therapy, Totally implantable venous access device, Lysosomal storage disorder
Reference Key
hendriksz2018molecularrisks Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Christian J. Hendriksz;Paul Harmatz;Roberto Giugliani;Jane Roberts;G. Suren Arul
Journal advances in skin & wound care
Year 2018
DOI
DOI not found
URL
http://www.sciencedirect.com/science/article/pii/S2214426918300156
Keywords
medicine (general)biology (general)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.